Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Sanders

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Microbiology|February 3, 2000
Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosaC C Sanders, M Peyret, E S Moland, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Penicillin-binding proteins and induction of AmpC beta-lactamaseC C Sanders, P A Bradford, A F Ehrhardt, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1988
Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriersD L Dworzack, C C Sanders, E A Horowitz, et al.
The Journal of Infectious Diseases|January 1, 1982
Resistance to cefamandole: a collaborative study of emerging clinical problemsC C Sanders, R C Moellering, R R Martin, et al.
The American Journal of Medicine|September 11, 1991
Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trialW E Sanders, J F Morris, P Alessi, et al.
Journal of Clinical Microbiology|June 28, 2001
Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospitalC C Sanders, M Peyret, E S Moland, et al.
Circulation|December 1, 1984
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the YoungS T Shulman, D P Amren, A L Bisno, et al.
American Journal of Diseases of Children (1960)|March 1, 1985
Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart AssociationS T Shulman, D P Amren, A L Bisno, et al.
Circulation|December 1, 1984
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the YoungS T Shulman, D P Amren, A L Bisno, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Microbiology|February 3, 2000
Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosaC C Sanders, M Peyret, E S Moland, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Penicillin-binding proteins and induction of AmpC beta-lactamaseC C Sanders, P A Bradford, A F Ehrhardt, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1988
Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriersD L Dworzack, C C Sanders, E A Horowitz, et al.
The Journal of Infectious Diseases|January 1, 1982
Resistance to cefamandole: a collaborative study of emerging clinical problemsC C Sanders, R C Moellering, R R Martin, et al.
The American Journal of Medicine|September 11, 1991
Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trialW E Sanders, J F Morris, P Alessi, et al.
Journal of Clinical Microbiology|June 28, 2001
Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospitalC C Sanders, M Peyret, E S Moland, et al.
Circulation|December 1, 1984
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the YoungS T Shulman, D P Amren, A L Bisno, et al.
American Journal of Diseases of Children (1960)|March 1, 1985
Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart AssociationS T Shulman, D P Amren, A L Bisno, et al.
Circulation|December 1, 1984
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the YoungS T Shulman, D P Amren, A L Bisno, et al.
Pageof 12